pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
THERAPEUTIC AREA
save

Dermatology

Diseases of the skin.

also known as: derm, skin

🐶 often sniffed alongside

top 8
  • tagRecall56 co-mentions · 33 sources
  • tagAdCom44 co-mentions · 30 sources
  • drugbenzoyl peroxide27 co-mentions · 7 sources
  • tag510(k) Clearance26 co-mentions · 23 sources
  • tagPMA Approval18 co-mentions · 7 sources
  • druginsulin10 co-mentions · 2 sources
  • tagOncology9 co-mentions · 4 sources
  • tagInfectious Disease7 co-mentions · 4 sources
drugs
300
catalysts
31
news
513
companies
242

Top drugs

view all →
Marketed
CLEOCIN
$PFE · 127 catalysts
Marketed
clindamycin hydrochloride
Bacterial Pneumonia
90 catalysts
Marketed
NALBUPHINE HYDROCHLORIDE
Pain
84 catalysts
Marketed
adalimumab
Intermediate Uveitis
$ABBV · 61 catalysts
Marketed
DOXYCYCLINE HYCLATE
$AMRX · 49 catalysts
Marketed
methylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts
Marketed
Efudex
Basal Cell Carcinoma (Basal Cell Epithelioma)
42 catalysts
Marketed
METHYLPREDNISOLONE ACETATE
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti…
41 catalysts

🐶 Top companies

view all →
  • $PFEPFIZER INC
    8 products
  • Teva Pharmaceuticals USA Inc
    6 products
  • Almirall SA
    5 products
  • PL Developments Copiague LLC
    4 products
  • PharmaTher Holdings Ltd
    4 products
  • $ABBVAbbVie Inc.
    3 products
  • $ACRSAclaris Therapeutics, Inc.
    3 products
  • Allergan Sales LLC
    3 products

Recent catalysts

view all →
Apr 30, 2026
phase 2 completion
7mo ago
Chinese Academy of Medical Sciences Plastic Surgery Hospital — recombinant type III humanized collagen (Phase II Trial Completion)
recombinant type III humanized collagen
→
Apr 30, 2026
phase 2 completion
7mo ago
Jetema Co Ltd — JTM-102 (Phase II Trial Completion)
JTM-102
→
Apr 30, 2026
phase 2 completion
7mo ago
Nigde Omer Halisdemir University — ozonated oil (Phase II Trial Completion)
ozonated oil
→
Apr 30, 2026
phase 2 completion
7mo ago
Vaidya Yagya Dutt Sharma Ayurvedic P. G. Mahavidhyalaya — ayurvedic medicine (Phase II Trial Completion)
ayurvedic medicine
→
Apr 30, 2026
phase 1 2 completion
7mo ago
Centre International de Développement Pharmaceutique — afamelanotide (Phase I/II Trial Completion)
afamelanotide
→
Apr 30, 2026
phase 1 2 completion
7mo ago
University Hospital Geneva — verteporfin (Phase I/II Trial Completion)
verteporfin
→
Apr 30, 2026
phase 1 initiation
$MRK143.37-0.75%
7mo ago
Merck & Co Inc — MK-6050 (Phase I Trial Initiation)
MK-6050
→
Apr 30, 2026
phase 1 initiation
7mo ago
Jiangsu Vcare PharmaTech Co Ltd — VC-005 (Phase I Trial Initiation)
VC-005
→
Apr 30, 2026
phase 0 trial completion
7mo ago
Foundation for the Promotion of Health and Biomedical Research of Valencia — Aquacel Ag + (Phase 0 Trial Completion)
Aquacel Ag +
→
Apr 30, 2026
phase 0 trial completion
7mo ago
Shanghai Jiao Tong University — insulin (Phase 0 Trial Completion)
insulin
→

Recent news

view all →
  • AstraZeneca, Calidi, Tempest make significant workforce cuts↗
    biospace · 1d ago
  • Aclaris drops TSLP program from pipeline after flunking phase 2 eczema test↗
    fiercebiotech · 2d ago
  • Deaths, failed trials and other recent setbacks in the autoimmune space↗
    biospace · 2d ago
  • Opinion: New organ donation rules are unfair to families↗
    stat · 5d ago
  • Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and Acetaminophen↗
    fda recalls · 6d ago
  • AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning↗
    biopharma dive · 7d ago
  • J&J and Protagonist’s Icotyde improves psoriatic arthritis but AbbVie’s Skyrizi likely to reign↗
    biospace · 9d ago
  • STAT+: Gene therapy’s long-debated cancer risk materializes↗
    stat · 9d ago
Data sources
openFDA · ClinicalTrials.gov · pharmadog Linker
last refreshed 8h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?